Objective: To survey drug use by breastfeeding women, and to compare this with nonbreastfeeding women. In addition, we were interested whether drug use was of influence on the decision to give breastfeeding, and the other way around. Design and setting: During a 6-week period in 2002, a questionnaire was handed out to all women with a child not older than 6 months, who visited a Well-Baby Clinic in the province of Friesland, the Netherlands, eventually resulting in 549 returned questionnaires (response 43%). Results: In all, 82.1% of the participants breastfed their baby at least at any time during the first 6 months after birth. More than half (65.9%) of all breastfeeding women had used drugs; however, they used drugs less frequently than nonbreastfeeding women (79.6%). The pattern of drug use differed: oral contraceptives, iron preparations, drugs for peptic ulcer, and several psychotropic drugs were more frequently used by nonbreastfeeding women, while vitamins were more frequently used by breastfeeding women. Drugs play an important role in women's decision to start or continue breastfeeding: women frequently hesitated to use drugs during breastfeeding, stopped either breastfeeding or drug use to avoid combining the two, took a measure to minimise exposure to the child, did not use any drug because of breastfeeding, or did not breastfeed because of drug use. Conclusions: Drugs are frequently though reluctantly used during breastfeeding, and play an important role in the decision to start and stop breastfeeding. Information how to deal with drugs seems therefore indispensable in efforts to promote breastfeeding.
Introduction
Human milk is considered the ideal nutrition for infants. Health, nutritional, immunological, developmental, psychological and social benefits are attributed to breastfeeding, and exclusive breastfeeding is therefore recommended for at least the first 4-6 months after birth (AAP, 2001; Yngve & Sjostrom, 2001) . Worldwide, several initiatives have been launched to promote breastfeeding and to help women to be successful at it, and as a consequence the prevalence of breastfeeding has increased in the last decade in many countries (Naylor, 2001; Wright, 2001; Yngve & Sjostrom, 2001 ). In the United States, the prevalence of initiation of breastfeeding and breastfeeding at 6 months of age were 69.5 and 32.5%, respectively, in 2001 (Ryan et al, 2002) . In Europe, these figures strongly differ per country. In Sweden, for example, almost 100% of the children receive breastfeeding directly after birth, and approximately 70% still receives breastfeeding at the age of 6 months (1996) , while in the Netherlands these figures are 80 and 34%, respectively (2001) (Yngve & Sjostrom, 2001; Lanting et al, 2002) .
Drug use by the mother may have an influence on breast milk. The milk volume may be decreased or increased by some drugs, and many drugs are transferred to the milk, resulting in exposure to the child (Bennet, 1996) . Although the general attitude is to be conservative with drug use during lactation, the number of drugs that are usually compatible with breastfeeding is much larger than the number of drugs that have been associated with adverse effects on infants (AAP, 2001) . For a number of drugs frequently used by women at the fertile age, such as certain anxiolytics and antidepressants, knowledge of the effects on the infant is still limited, and use of these drugs during lactation thus warrants caution.
Despite the increased attention for breastfeeding, information about drug utilisation during lactation is scarce. The most extensive study originates from Norway, and showed that in 1985 25% of the breastfeeding mothers with children aged 3-5 months had used at least one drug in the preceding 2 weeks (Matheson et al, 1990) . Several other studies described drug use in the postpartum period, but did not distinguish between breastfeeding and nonbreastfeeding women (Passmore et al, 1984; CGDUP, 1992; Olsesen et al, 1999a, b) . An example is a study from 1999 among 16 001 Danish women that showed that 34% of the women took up a prescription in the 3 months after birth (Olesen et al, 1999a) . Taking all together, the available studies show that the most commonly used drugs in the postpartum period are analgesics, laxatives, vitamins, antiinfectives, antiemetics, sedatives and hypnotics.
The present survey was undertaken to get recent information of the drug use among breastfeeding women The specific aims were to determine the extent of drug use by breastfeeding women, to determine the types of drugs that these women use, and to compare these figures with nonbreastfeeding women. In addition, the influence of drug use on the decision to give breastfeeding, and the influence of breastfeeding on the decision to use the drugs were examined.
Methods

Population
In the Netherlands, 98% of infants are taken to a Well-Baby Clinic for vaccinations, check-ups and advice regarding growth, development and health (De Pree-Geerlings et al, 2001) . Usually, the first visit takes place at the age of 4 weeks, and in the first half-year mothers (or fathers) and their children visit the well-baby clinic approximately once per month. For this study, two of the three Home Care organisations in the province of Friesland co-operated. Together these organisations run 85 Well-Baby Clinics in the region. On average, these clinics are open one to three times a month, and are visited by 10-15, and sometimes up to 30 mothers and their children each time.
Design and analysis During a 6-week period in November-December 2002, all 85 Well-Baby Clinics handed out a short questionnaire to all mothers visiting the Well-Baby Clinic with a child not older than 6 months. Women were asked to fill in the questionnaire at home, and to return the anonymously filled-in questionnaire in a prepaid envelope. If a mother visited the Well-Baby Clinic more than once in the study period, only one questionnaire was handed out. If someone else than the mother came to the Well-Baby Clinic with the child, he or she was asked to hand over the questionnaire to the mother. The questionnaire consisted of a short list of questions that could be filled in within 5 min. Questions concerned among others demographic characteristics (as age of the child, age and education of the mother and parity), the use of drugs, breastfeeding practices, and considerations related to breastfeeding and the use of drugs. All women were asked to fill in the questionnaire regardless of breastfeeding and drug use. To estimate the response rate, all clinics were asked to return the questionnaires that had not been handed out.
Breastfeeding was defined as all feeding practices in combination with breast milk (thus exclusive breastfeeding (EBF), complementary feeding (CBF), and pumping breast milk to feed the child at a later time). Drugs were defined as all prescribed and nonprescribed medicines, including oral contraceptives, vitamins and homeopathic preparations. All women were categorised into one of the following groups:
(1) breastfed her child for at least a part of the preceding 6 months, and used at least one drug in the period of breastfeeding; (2) breastfed her child for at least a part of the preceding 6 months, but did not use any drug in the period of breastfeeding; (3) never breastfed her child in the preceding 6 months, but did use drugs is this period; and (4) never breastfed her child in the preceding 6 months, and used no drugs in this period. Demographic characteristics were compared between these groups, and differences were tested with a one-way ANOVA or w 2 test, when appropriate.
The duration of breastfeeding was analysed using the Kaplan-Meier estimator, and a logrank test was performed to investigate a difference in the duration of breastfeeding between women who had used drugs during breastfeeding and women who had not. Women were specifically asked for the use of 30 drug groups, described by indication as much as possible, and provided with examples of drug names. Drug use was compared between breastfeeding women and nonbreastfeeding women, and differences were tested with a w 2 test with Yates' continuity correction or Fisher's exact test for drugs that were not frequently used. Further, considerations related to combining drugs and breastfeeding were examined by asking the level of agreement of several statements. All analyses were performed with SPSS 11.0.
Results
In total, 549 questionnaires were returned, and based on the number of blank questionnaires returned by the Well-Baby Clinics, it was calculated that the response rate was approximately 43%. Of all respondents, 82.1% breastfed her child for at least a part of the preceding 6 months of whom 65.9% used at least one drug in the period of breastfeeding. Further, 17.9% never breastfed her child in the preceding 6 months, of whom 79.6% did use drugs in this period. There were no statistically significant differences 4.4) . Of the breastfeeding women 43.9% reported they had no other children, while in nonbreastfeeding women this figure was 47.2%. The percentages of drug-using women who breastfed at 1, 3 and 6 months were estimated as 74, 61 and 48%, respectively; among women who had not used drugs these figures were 77, 51 and 30% (P ¼ 0.02, logrank test). Table 1 shows drug use of breastfeeding women and nonbreastfeeding women in more detail. Drug use was highest among nonbreastfeeding women: 79.6% of the nonbreastfeeding women had used drugs, compared to 65.9% of the breastfeeding women. If iron, vitamins and homeopathic preparations were not taken into account, these figures were 75.5 and 53.0%. The major differences were that oral contraceptives, iron preparations, drugs for peptic ulcer and several psychotropic drugs were more frequently used by nonbreastfeeding women, while vitamins were more frequently used by breastfeeding women.
Although the majority of the women did not hesitate to combine breastfeeding and drug use, still 30.0% did hesitate (Table 2) . Almost 10% stopped either breastfeeding or drug use to avoid combining the two, and in addition approximately 5% took a measure to minimise exposure to the child (for instance, expressing breast milk before drug use, breastfeeding just before intake of the drug, etc.). Of the women who breastfed, but had not used any drugs, almost one out of six indicated she would have used a drug if she had not breastfeed. Interestingly, besides oral contraceptives, paracetamol was frequently mentioned, a drug that is safe to use during lactation. Finally, nine of the 78 (11.5%) women who had not breastfed indicated that this was because of a drug. 
Discussion
The major findings of our study are that approximately 82% of the women breastfed their baby at least some time during the first 6 months after birth. More than half (65.9%) of all breastfeeding women had used drugs, but they used drugs less frequently than nonbreastfeeding women (79.6%). Also, the pattern of drug use differed: oral contraceptives, iron preparations, drugs for peptic ulcer and several psychotropic drugs were more frequently used by nonbreastfeeding women, while vitamins were more frequently used by breastfeeding women. Further, we showed that drugs play an important role in the decision on starting and continuation of breastfeeding: women frequently hesitated to use drugs during breastfeeding, stopped either breastfeeding or drug use to avoid combining the two, took a measure to minimise exposure to the child, did not use drugs because of breastfeeding, or did not breastfeed because of drug use. The use of postal questionnaires as a source for drug utilisation information has several limitations. Selective returning of the questionnaires may induce response bias. As the response rate in our study was 43% this may influence the interpretation of our findings. The percentage of our respondents who had finished a middle-level education and high-level education were 56 and 29%, respectively (data not shown). Since in the female work force (15-64 y) these percentages are 43 and 16% in the province of Friesland (Statistics Netherlands), women with higher education seem to be over-represented in our study. As both breastfeeding and low drug use are to some degree related to social class and/or education, it might be expected that our results are somewhat biased towards a higher proportion of breastfeeding women, and a lower use of drugs (Henricson et al, 1999; Bulk-Bunschoten et al, 2001) . Another methodological issue inherent to retrospective questioning is the possibility that women may have forgotten to report certain medications, resulting in recall bias. We tried to minimise the possibility of recall bias by using indication-oriented questions (Mitchell et al, 1986; De Jong-van den Berg et al, 1993) . A study among Dutch mothers using this approach showed that mothers were able to report 76% of drug groups used (De Jong-van den Berg et al, 1999) .
Our findings of a predominant use of analgesics, vitamins, anti-infective drugs and antiaenemic preparations (iron) is very well comparable to earlier findings of a study among breastfeeding women in Norway, and several other studies on the postpartum period (Passmore et al, 1984; Matheson et al, 1990; CGDUP, 1992; Olsesen et al, 1999a,b) . The fact that none of the 549 women used blood sugar lowering agents may seem surprising, but is not unlikely since the prevalence of diabetes mellitus in the Netherlands for women at the fertile age lies around 4/1000).
Differences in drug utilisation between breastfeeding women and nonbreastfeeding women might be influenced by the fact that some drugs inhibit milk production, and are therefore less likely to be used by breastfeeding women. Some drugs are specially indicated for this purpose, such as the dopaminergic agent bromocriptine. For other drugs, however, it might be a matter of an unintentional side effect, such as oestrogen-including oral contraceptives, ergot alkaloids and diuretics. In addition to the contraceptive effect of breastfeeding itself, this is likely to be the reason for the low contraceptive use among breastfeeding women. Interestingly, drugs against postpartum haemorrhages are less frequently used by breastfeeding women, a finding in line with the phenomenon that breastfeeding increases the levels of oxytocine, resulting in less postpartum bleeding (Chua et al, 1994) . However, cautiousness with ergot alkaloids in the treatment of postpartum bleeding in women planning to breastfeed might also have played a role.
Differences in drug utilisation between breastfeeding women and nonbreastfeeding women may also be influenced by some selection mechanisms: less healthy women Drug use during breastfeeding E Schirm et al may prefer not to breastfeed, and as we have shown in this study, women sometimes decide not to breastfeed because of drug use. Further, breastfeeding may benefit the mother's physical and psychological health, possibly resulting in less drug use. Assuming that these sources of bias do not explain the entire difference between both groups, our findings suggest that breastfeeding women are cautious with drugs, and tend to minimise the use of drugs that are not strictly needed, such as certain psychotropic drugs. This view is strengthened by our findings that many breastfeeding women hesitate to use drugs, and women frequently avoid combining breastfeeding and drug use by omitting one of the two. In a study in Norway, Matheson et al (1990) found that more than half of the breastfeeding women believed that the risk of drug use during lactation was similar or higher than use of the same drugs during pregnancy. Since the opposite is trueFthe majority of drugs can be safely used during lactationFinformation about how to deal with drugs seems very important in programmes to promote breastfeeding (AAP, 2001) . Illustrative is the fact that several nondrugusing breastfeeding women, who indicated they would have used a drug if not breastfeeding, mentioned paracetamol, a drug that is safe to use during lactation. The percentages of women still breastfeeding at 3 and 6 months were higher among drug-using women than among nondrug-using women. We can only speculate on the reasons for this difference (61 and 48% vs 51 and 30%, respectively). Perhaps breastfeeding women using drugs were more likely to return the questionnaires. Also, women may have stopped breastfeeding because they needed to use a drug. The available data of our research does not offer sufficient detailed information to answer these questions; it seems worthwhile to ask this more specifically in future research.
We conclude that drugs are frequently although reluctantly used during breastfeeding. Drugs play an important role in the decision to start and stop breastfeeding, and information how to deal with drugs seems therefore indispensable in efforts to promote breastfeeding.
